Corda Investment Management’s AbbVie ABBV Stock Holding History

Corda Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Buy	5,274 +41	+0.8%	+$9.1K	0.08%	72
2025 Q4	$1.2M	Sell	5,233 -547	-9%	-$125K	0.09%	77
2025 Q3	$1.34M	Sell	5,780 -117	-2%	-$23.8K	0.09%	72
2025 Q2	$1.09M	Sell	5,897 -735	-11%	-$137K	0.08%	77
2025 Q1	$1.39M	Sell	6,632 -885	-12%	-$172K	0.11%	61
2024 Q4	$1.34M	Buy	7,517 +63	+0.8%	+$11.6K	0.11%	62
2024 Q3	$1.47M	Sell	7,454 -1,168	-14%	-$218K	0.11%	60
2024 Q2	$1.48M	Buy	+8,622	New	+$1.43M	0.12%	60

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Corda Investment Management's ABBV Position: Q1 2026 in Review

Corda Investment Management increased its AbbVie (ABBV) stake by 0.78% in Q1 2026, buying an estimated $9.1K and bringing the position to 5,274 shares worth $1.15M. The position accounts for 0.08% of the portfolio, ranked #72.

Corda Investment Management first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.48M in Q2 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Corda Investment Management held 5,274 shares of AbbVie worth $1.15M as of Q1 2026.
Corda Investment Management bought 41 AbbVie shares in Q1 2026, an estimated $9.1K.
AbbVie made up 0.08% of Corda Investment Management's portfolio in Q1 2026, its #72 holding.
Corda Investment Management first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
Corda Investment Management's AbbVie position peaked at $1.48M in Q2 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Corda Investment Management's 13F filing for Q1 2026, filed 4 May 2026.